The president is to appear at midday at the U.S.-Saudi Investment Forum with the crown prince, according to a schedule ...

In our news wrap Tuesday, Pfizer agreed to cut prescription drug prices as part of a deal that spares the company from certain tariffs on its imports, Hamas says it will review a peace plan for Gaza ...

The lobby group representing US drug giants says Australia’s drug pricing policies are harming American innovation and jobs.

Pfizer Inc. Chief Executive Albert Bourla said the company secured a three-year grace period from President Trump’s promised tariffs on pharmaceuticals in a deal that would lower some of the company’s ...

Pfizer signed a deal with the White House to help Americans pay lower prices for prescription drugs. This agreement removes the uncertainty hanging over Pfizer's head related to the Trump ...

Pfizer secured a reprieve from President Donald Trump’s long-threatened tariffs on the pharmaceutical industry Tuesday by agreeing to slash some of its drug prices by up to 85% and selling directly to ...

Pfizer (NYSE: PFE) is no stranger to income investors. The drugmaker, famous for treatments including Lipitor, Viagra, and Zoloft, has now increased its dividend payout for 16 consecutive years. And ...

Pfizer is facing a landmark lawsuit in the US brought on behalf of more than 1,000 women who say they developed brain tumors after taking the popular contraceptive injection Depo-Provera. On Monday, ...

Pfizer is one of the world's largest and oldest drug companies. Thanks to its Covid vaccine, shares rose dramatically during the pandemic. Now that the stock has sharply corrected, long-term investors ...

Pfizer Inc. will acquire Metsera, Inc. for up to $7.5 billion, which significantly expands PFE's obesity and cardiometabolic pipeline. The acquisition addresses Pfizer's internal obesity pipeline ...

Pfizer is acquiring a pharma company that has multiple GLP-1 drugs in development. The deal may cost the company up to $7.3 billion, which is a move Pfizer can afford to make given its strong ...

Pfizer is one of the world's largest pharmaceutical companies. It has a few material patent expirations on the horizon. It's doing what it has to do to deal with that headwind and others. The 6.7% ...